Ledger.Open graph →
SEC Form D · filed July 16, 2020

Opal Biosciences, Inc

Offering
$75.0M
Sold
$1.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
NEW YORK, NY
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (10)

Michael Ehlers · New York, NYDirectorSeth Harrison · Cambridge, MADirectorRajesh H. Chopra · New York, NYDirectorJames H. Doudna Cate · New York, NYDirectorSpiros Liras · New York, NYExec · DirectorMichael Ehlers · New York, NYDirectorSeth Harrison · New York, NYDirectorRajesh H. Chopra · New York, NYDirectorJames H. Doudna Cate · New York, NYDirectorSpiros Liras · New York, NYExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗